Clinical Trial Update: Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluating teriflunomide in radiologically isolated syndrome for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED